marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-07-2024
Ocular Therapeutix Cash Flow 2011-2024 | OCUL
Annual Cash Flow Ocular Therapeutix
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-70.2 M | -59.6 M | -65.6 M | -53.6 M | -77.6 M | -49.2 M | -50.5 M | -34 M | -33.7 M | - | - | - | - |
Depreciation & Amortization |
2.98 M | 2.11 M | 2.42 M | 2.77 M | 2.53 M | 2.29 M | 1.62 M | 881 K | 754 K | 547 K | 404 K | 404 K | - |
Accounts Payables |
4.39 M | 5.12 M | 4.59 M | 2.71 M | 3.27 M | 2.96 M | 3.57 M | 2.12 M | 1.96 M | 1.32 M | - | - | - |
Accounts Receivables |
26.2 M | 21.3 M | 21.1 M | 12.3 M | 2.55 M | 201 K | 226 K | 250 K | 193 K | 329 K | - | - | - |
Total Inventories |
2.3 M | 1.97 M | 1.25 M | 1.2 M | 954 K | 217 K | 122 K | 113 K | 134 K | 133 K | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Ocular Therapeutix
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -33.9 M | - | - | - | -20 M | - | -42.6 M | -29.5 M | -18.6 M | - | -50.4 M | -37.4 M | -17.4 M | - | -47.3 M | -33.6 M | -18.9 M | - | -58.1 M | -38.6 M | -19.4 M | - | -35.6 M | -24.7 M | -12.5 M | - | -40.1 M | -25.7 M | -14.6 M | - | -26.4 M | -19.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | 920 K | - | - | - | 483 K | - | 1.62 M | 1.11 M | 557 K | - | 1.85 M | 1.26 M | 646 K | - | 2.11 M | 1.44 M | 734 K | - | 1.86 M | 1.19 M | 589 K | - | 1.7 M | 1.13 M | 565 K | - | 1.1 M | 615 K | 261 K | - | 628 K | 412 K | 205 K | - | 554 K | 360 K | 173 K | - | 383 K | 244 K | 93 K | - | 279 K | 187 K | - | - | - | - | - | - | - | - | - |
Accounts Payables |
3.69 M | 6.45 M | 4.39 M | 3.98 M | 3.57 M | 5.44 M | 5.12 M | 5.31 M | 3.7 M | 3.42 M | 4.59 M | 4.25 M | 3.88 M | 4.15 M | 2.71 M | 2.71 M | 2.71 M | 2.71 M | 3.27 M | 3.27 M | 3.27 M | 3.27 M | 2.96 M | 2.96 M | 2.96 M | 2.96 M | 3.57 M | 3.57 M | 3.57 M | 3.57 M | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 1.96 M | 1.96 M | 1.96 M | 1.96 M | 1.32 M | 1.32 M | 1.32 M | 1.32 M | 545 K | 545 K | 545 K | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
30.2 M | 26.5 M | 26.2 M | 23.6 M | 27.3 M | 21.1 M | 21.3 M | 19.8 M | 20.5 M | 23.2 M | 21.1 M | 19.6 M | 18.7 M | 13.6 M | 12.3 M | 12.3 M | 12.3 M | 12.3 M | 2.55 M | 2.55 M | 2.55 M | 2.55 M | 201 K | 201 K | 201 K | 201 K | 226 K | 226 K | 226 K | 226 K | 250 K | 250 K | - | - | 193 K | 189 K | 164 K | 352 K | 329 K | 329 K | 329 K | 329 K | 250 K | 250 K | 250 K | - | - | - | - | - | - | - | - | - |
Total Inventories |
2.55 M | 2.57 M | 2.3 M | 2.26 M | 2.2 M | 2.27 M | 1.97 M | 1.54 M | 1.5 M | 1.36 M | 1.25 M | 1.22 M | 1.11 M | 1.12 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 954 K | 954 K | 954 K | 954 K | 217 K | 217 K | 217 K | 217 K | 122 K | 122 K | 122 K | 122 K | 113 K | 113 K | 113 K | 113 K | 134 K | 134 K | 134 K | 134 K | 133 K | 133 K | 133 K | 133 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency